Literature DB >> 18480989

Effect of epimedium-derived phytoestrogen on bone turnover and bone microarchitecture in OVX-induced osteoporotic rats.

Songlin Peng1, Renyun Xia, Huang Fang, Feng Li, Anmin Chen, Ge Zhang, Ling Qin.   

Abstract

To investigate the preventive effect of epimedium-derived phytoestrogen (PE) on osteoporosis induced by ovariectomy (OVX) in rats, 11-month-old female Wistar rats were randomly divided into Sham, OVX and PE groups. One week after OVX, daily oral administration of PE (0.4 g.kg(-1).day(-1)) started in PE group, and rats in Sham and OVX groups were given vehicle accordingly. The administrations lasted for 12 weeks. The biological markers including serum osteocalcin (OC) and urinary deoxypyridinoline (DPD) for bone turnover were evaluated at the end of the 12th week. On the 13th week, all the rats were sacrificed. The right proximal tibiae were removed, subjected to micro CT for determination of trabecular bone structure and then bone histomorphometry was performed to assess bone remodeling. The OVX rats were in a high bone turnover status as evidenced by increased bone formation markers and bone resorption markers. Treatment with PE could suppress the high bone turnover rate in OVX rats. Micro CT data revealed that PE treatment could ameliorate the deterioration of the micro-architecture of proximal tibiae induced by OVX, as demonstrated by greater bone volume, increased trabecular thickness and less trabecular separation in PE group in comparison with OVX group. The static and dynamic parameters of bone histomorphometry indicated that there were significant increases in bone formation variables and significant decreases in bone resorption variables between PE and OVX groups. The findings suggest that PE has a beneficial effect on trabecular bone in OVX rat model and this effect is possibly associated with stimulation of bone formation as well as inhibition of bone resorption.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18480989     DOI: 10.1007/s11596-008-0213-7

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  6 in total

1.  Flavonoids derived from herbal Epimedium Brevicornum Maxim prevent OVX-induced osteoporosis in rats independent of its enhancement in intestinal calcium absorption.

Authors:  G Zhang; L Qin; W Y Hung; Y Y Shi; P C Leung; H Y Yeung; K S Leung
Journal:  Bone       Date:  2006-01-18       Impact factor: 4.398

2.  Basic fibroblast growth factor improves trabecular bone connectivity and bone strength in the lumbar vertebral body of osteopenic rats.

Authors:  Wei Yao; Tamer Hadi; Yebin Jiang; Jeff Lotz; Thomas J Wronski; Nancy E Lane
Journal:  Osteoporos Int       Date:  2005-08-05       Impact factor: 4.507

Review 3.  Monitoring osteoporosis therapy: bone mineral density, bone turnover markers, or both?

Authors:  Sydney Lou Bonnick; Lee Shulman
Journal:  Am J Med       Date:  2006-04       Impact factor: 4.965

4.  Hormone replacement therapy in relation to breast cancer.

Authors:  Chi-Ling Chen; Noel S Weiss; Polly Newcomb; William Barlow; Emily White
Journal:  JAMA       Date:  2002-02-13       Impact factor: 56.272

5.  Phytoestrogen-rich herb formula "XLGB" prevents OVX-induced deterioration of musculoskeletal tissues at the hip in old rats.

Authors:  Ling Qin; Ge Zhang; Wing-Yin Hung; Yinyu Shi; Kwoksui Leung; Hiu-Yan Yeung; Pingchung Leung
Journal:  J Bone Miner Metab       Date:  2005       Impact factor: 2.626

6.  Bone microarchitecture of the calcaneus and its changes in aging: a histomorphometric analysis of 60 human specimens.

Authors:  Martin Rupprecht; Pia Pogoda; Marcus Mumme; Johannes M Rueger; Klaus Püschel; Michael Amling
Journal:  J Orthop Res       Date:  2006-04       Impact factor: 3.494

  6 in total
  1 in total

1.  Beneficial Role of Hydro-alcoholic Seed Extract of Trigonella foenum graecum on Bone Structure and Strength in Menopause Induced Osteopenia.

Authors:  K Anjaneyulu; Kumar Mr Bhat; S R Srinivasa; R A Devkar; T Henry
Journal:  Ethiop J Health Sci       Date:  2018-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.